Docket
117th Congress · HOUSE BILLBILL

H.R. 467 — Protecting Patient Access to Lifesaving COVID–19 Drugs Act of 2021

“To amend the Families First Coronavirus Response Act and the CARES Act to require group health plans and health insurance issuers offering group or individual health insurance coverage to provide coverage, without cost sharing, of certain COVID-19 antibody treatments.”

Health
Introduced Jan 25, 2021
Last action Feb 2, 2021
Pipeline · Bill → Law
Step 1
Introduced
Jan 25, 2021
Step 2
Referred
Feb 2, 2021
Education and Workforce · E&C · Ways & Means
Step 3
Committee
Step 4
House floor
Step 5
Senate
Step 6
Resolve Changes
Step 7
Signed
SummaryNo summary available

No CRS summary available for this bill.

Provisions · 2 sectionsIntroduced in House
Timeline · 6 actions
Feb 2, 2021
Referred to the Subcommittee on Health.
Jan 25, 2021
Introduced in House
Jan 25, 2021
Referred to the Subcommittee on Health.
Jan 25, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jan 25, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jan 25, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.